These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10981069)

  • 1. Relevance of heart rate as a risk factor in hypertension.
    Palatini P; Julius S
    Curr Hypertens Rep; 1999 Jun; 1(3):219-24. PubMed ID: 10981069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate as a risk factor for atherosclerosis and cardiovascular mortality: the effect of antihypertensive drugs.
    Palatini P
    Drugs; 1999 May; 57(5):713-24. PubMed ID: 10353296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated heart rate as a predictor of increased cardiovascular morbidity.
    Palatini P
    J Hypertens Suppl; 1999 Aug; 17(3):S3-10. PubMed ID: 10489092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of tachycardia with morbidity and mortality: pathophysiological considerations.
    Palatini P; Julius S
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S19-27. PubMed ID: 9321736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic overactivity in hypertension: a risk factor for cardiovascular disease.
    Palatini P
    Curr Hypertens Rep; 2001 Sep; 3 Suppl 1():S3-9. PubMed ID: 11580882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The physiological determinants and risk correlations of elevated heart rate.
    Palatini P; Julius S
    Am J Hypertens; 1999 Jan; 12(1 Pt 2):3S-8S. PubMed ID: 10077413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness of α2-adrenoceptor/I1-imidazoline receptor in the rostral ventrolateral medulla to cardiovascular regulation is enhanced in conscious spontaneously hypertensive rat.
    Yamazato M; Nakamoto M; Sakima A; Yamazato Y; Takishita S; Ohya Y
    Clin Exp Hypertens; 2019; 41(3):255-262. PubMed ID: 29764227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sympathetic overactivity on cardiovascular prognosis in hypertension.
    Julius S
    Eur Heart J; 1998 Jun; 19 Suppl F():F14-8. PubMed ID: 9651730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
    Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central origin of decreased heart rate variability in patients with cardiovascular diseases.
    Wolk R
    Med Hypotheses; 1996 May; 46(5):479-81. PubMed ID: 8735888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction.
    Grassi G; Seravalle G; Quarti-Trevano F; Dell'Oro R; Arenare F; Spaziani D; Mancia G
    Hypertension; 2009 Feb; 53(2):205-9. PubMed ID: 19124679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. I1-imidazoline-receptor agonists in the treatment of hypertension: an appraisal of clinical experience.
    Ollivier JP; Christen MO
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S39-48. PubMed ID: 7533226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated heart rate: a major risk factor for cardiovascular disease.
    Palatini P; Julius S
    Clin Exp Hypertens; 2004; 26(7-8):637-44. PubMed ID: 15702618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing face of sympathetic overactivity in hypertension.
    Julius S; Majahalme S
    Ann Med; 2000 Jul; 32(5):365-70. PubMed ID: 10949068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate as a cardiovascular risk factor: do women differ from men?
    Palatini P
    Ann Med; 2001 May; 33(4):213-21. PubMed ID: 11405541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resting Heart Rate as a Cardiovascular Risk Factor in Hypertensive Patients: An Update.
    Palatini P
    Am J Hypertens; 2021 Apr; 34(4):307-317. PubMed ID: 33447842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical consequences of the autonomic imbalance in hypertension and congestive heart failure.
    Julius S; Nesbitt S
    Scand Cardiovasc J Suppl; 1998; 47():23-30. PubMed ID: 9540130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evidence for a pathophysiologic significance of the sympathetic overactivity in hypertension.
    Julius S
    Clin Exp Hypertens; 1996; 18(3-4):305-21. PubMed ID: 8743023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.